Mondelez International (MDLZ) FY2025 10-K Annual Report
Mondelez International (MDLZ) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Feb 4, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Mondelez International FY2025 10-K Analysis
Business Overview
- • Core business model: Manufacture and sale of global and local snack brands, focused on chocolate, biscuits, and baked snacks
- • New product emphasis: Co-branded chocolate innovations (Biscoff with Cadbury Dairy Milk, Milka), zero sugar Bournvita in India, and expanded cake/pastry lines including Oreo Cakester, Milka and Lacta croissants
Management Discussion & Analysis
- • Revenue trends not explicitly stated; experienced pricing impacts and currency-related items totaling favorable $241M on Organic Net Revenue in 2025
- • Adjusted Operating Income affected by $94M favorable currency items; restructuring and ERP costs increased ($3M restructuring, $163M ERP in 2025) with margin impact unspecified
Risk Factors
- • Regulatory risk from potential trade and tariff actions affecting countries where Mondelez operates, impacting global operations and costs
- • Macroeconomic volatility exposing Mondelez to currency fluctuations and inflation pressures in key international markets
Mondelez International FY2025 Key Financial MetricsXBRL
Revenue
$38.5B
▲ +5.8% YoY
Net Income
$2.5B
▼ -46.8% YoY
Gross Margin
28.4%
▼ -1075bp YoY
Operating Margin
9.2%
▼ -820bp YoY
Net Margin
6.4%
▼ -629bp YoY
ROE
9.5%
▼ -763bp YoY
Total Assets
$71.5B
▲ +4.4% YoY
EPS (Diluted)
$1.89
▼ -44.7% YoY
Operating Cash Flow
$4.5B
▼ -8.1% YoY
Source: XBRL data from Mondelez International FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Mondelez International
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.